Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia

Thrombopoietin-receptor agonists have been recently introduced for a second-line treatment of immune thrombocytopenia (ITP). Splenectomy has tended to be avoided because of its complications, but the response rate of splenectomy is 60–80% and it has still been considered for steroid-refractory ITP....

Ausführliche Beschreibung